Series B funding round for Denali Therapeutics raising $130M in August 2016
Series B funding round for Denali Therapeutics raising $130M in August 2016
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$350M
Top Valuation
-
Denali Therapeutics raised $130M in a Series B round.
The round was announced on 08/01/16.